Drug treatment programs' HCV service delivery to their HCV positive clients*

Author： Astone-Twerell Janetta M.   Strauss Shiela M.   Hagan Holly   Des Jarlais Don C.  

Publisher： Informa Healthcare

ISSN： 1606-6359

Source： Addiction Research and Theory, Vol.14, Iss.3, 2006-06, pp. : 289-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlates of Drug Treatment Program Staff's Self Efficacy to Support Their Clients' Hepatitis C Virus (HCV) Related Needs

By Strauss Shiela M.   Astone-Twerell Janetta M.   Munoz-Plaza Corrine   Jarlais Don C. Des   Gwadz Marya   Hagan Holly   Osborne Andrew   Rosenblum Andrew  

The American Journal of Drug and Alcohol Abuse, Vol. 33, Iss. 2, 2007-03 ,pp. : 245-251

Informa Healthcare

Access to resources Recommend Favorite

Treatment of HBV/HCV coinfection

By Potthoff Andrej   Manns Michael P   Wedemeyer Heiner  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 919-928

Informa Healthcare

Access to resources Recommend Favorite

Alisporivir for the treatment of chronic HCV

By Azzaroli Francesco   Turco Laura   Lisotti Andrea   Cecinato Paolo   Calvanese Claudio   Buonfiglioli Federica   Cevenini Monica   Montagnani Marco   Mazzella Giuseppe  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 9-18

Future Medicine

Access to resources Recommend Favorite

The emerging field of HCV drug resistance

By Koev Gennadiy   Kati Warren  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 303-319

Informa Healthcare

Access to resources Recommend Favorite

Residential Substance User Treatment Programs as Venues for HCV Pharmacological Treatment: Client and Staff Perspectives

By Strauss Shiela   Astone Janetta   Munoz-Plaza Corrine   Hagan Holly   Jarlais Don  

Substance Use & Misuse, Vol. 40, Iss. 12, 2005-11 ,pp. : 1811-1829

Informa Healthcare

Access to resources Recommend Favorite